Why Catalyst Metals, Imugene, Red 5, and Telstra shares are pushing higher today

These shares are outperforming on Wednesday. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down 0.2% to 7,811.7 points.

Four ASX shares that are not letting that hold them back today are listed below. Here's why they are rising:

A man wearing glasses and a white t-shirt pumps his fists in the air looking excited and happy about the rising OBX share price

Image source: Getty Images

Catalyst Metals Ltd (ASX: CYL)

The Catalyst Metals share price is up 13% to $1.29. This morning, this gold miner released an production update. According to the release, Catalyst Metals achieved annual group production of 110,000 ounces for FY 2024. This group gold production includes the first 12 months of Plutonic production under Catalyst's ownership following the consolidation of the Plutonic Gold Belt on 1 July 2023. The Plutonic operation produced 85,000 ounces for FY 2024, which is up from 60,000 ounces in FY 2023. This represents a 41% increase with only an $11 million increase in costs. Its CEO, James Champion de Crespigny, commented: "Now, with Plutonic stabilising, we are able to focus on developing Trident and Plutonic East which will see our production grow to over 150koz."

Imugene Ltd (ASX: IMU)

The Imugene share price is up 6% to 5.4 cents. This has been driven by news that the clinical stage immune-oncology company has dosed its first patient in its trial for bile tract cancer patients. Imugene's trial is an expansion of its MAST Phase 1 trial. It was undertaken after early responses were observed in gastrointestinal cancers, and particularly bile tract cancers. The trial is testing Imugene's cancer-killing virus CF33 (Vaxinia). The company's CEO, Leslie Chong, said: "Given the results we've seen to date we are eager to see the potential of VAXINIA in bile tract cancer."

RED 5 Limited (ASX: RED)

The Red 5 share price is up 2% to 40.8 cents. Investors have been buying this gold miner's shares this week after it entered into a restructured hedge facility and security package, repaid all outstanding loans, and restructured the hedging from the legacy Silver Lake Resources Limited (ASX: SLR) common terms deed. It also revealed that preliminary group sales for the fourth quarter were 110,818 ounces of gold, bringing its full year sales to 455,259 ounces of gold.

Telstra Group Ltd (ASX: TLS)

The Telstra Group share price is up 2.5% to $3.82. Investors have been buying the telco giant's shares this week after it announced an increase to its mobile prices. This will see prices on most of its mobile plans increase by between $2 to $4 per month. Goldman Sachs was pleased with the news and believes it demonstrates that the mobile market remains rational. In addition, it boosted its earnings and dividend estimates to reflect the changes. This ultimately led to the broker retaining its buy rating and lifting its price target to $4.30.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Three men stand on a winner's podium with medals around their necks and their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lukewarm but positive start to the trading week today.

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Healthcare Shares

How CSL shares skyrocketed 39% in August

Investors sent CSL shares rocketing 39% in August. But why?

Read more »

Hands reaching high for a trophy with a sunset in the background.
Share Gainers

The 5 best ASX 200 stocks to buy and hold in August revealed

Investors sent these five ASX 200 stocks rocketing 35% to 44% in August. But why?

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a bleak start to the week this Monday.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the week for investors this Friday.

Read more »

Man rocketing in the sky.
Share Gainers

3 ASX 200 stocks, including Paladin Energy, storming higher on earnings results this week

Investors sent Paladin Energy shares and these two popular ASX 200 stocks soaring following strong earnings results.

Read more »

Three rock climbers hang precariously off a steep cliff face, each connected to the other with the higher person holding on and the two below them connected by their arms and rope but not making contact with the cliff face.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rather nasty Thursday session for investors.

Read more »

Three women athletes lie flat on a running track as though they have had a long hard race where they have fought hard but lost the event.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing showing from the market this hump day.

Read more »